Journal
GUT MICROBES
Volume 2, Issue 4, Pages 262-266Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/gmic.2.4.17692
Keywords
antimicrobial peptides; human beta defensin 1; disulphide bridges; thioredoxin; redox-modulation; mucosal host defence; intestinal microbiota; commensal bacteria; innate immunity
Categories
Funding
- Deutsche Forschungsgemeinschaft [WE 436/1-1]
- Robert-Bosch-Foundation Stuttgart
Ask authors/readers for more resources
A ntimicrobial peptides are key players of the innate immune system and form a primary barrier against infection by microorganisms. In humans, several classes of antimicrobial peptides are produced, including the defensins. These small, cationic peptides show broad spectrum antimicrobial activity against bacteria, some fungi and some viruses. Defensins are characterized by six conserved cysteine residues which are connected via three disulphide bridges. Depending o n the pattern of connectivity, human defensins are either classified as alpha- or beta-defensins. Human beta-defensin 1 (hBD-1) is constitutively expressed by epithelia, but in comparison with other antimicrobial peptides the antimicrobial activity of hBD-1 was comparably low. We recently found that after reduction of hBD-1's three disulphide bonds its antimicrobial activity is strongly enhanced. Reduction can be either performed by a reducing environment, as it is present in parts of the human intestine, the oral cavity and other locations, or enzymatically by the thioredoxinsystem, which is one of the major redox regulators. Reduced hBD-1 is able to kill Gram-positive anaerobic bacteria of the human normal flora as well as an opportunistic pathogenic fungus, whereas the oxidized peptide does not show activity against these microorganisms. Herein we provide additional data about reduced hBD-1 and discuss the biological context of our findings.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available